ZHU Jing, LI Xiangcheng, YIN Rong. Effect of pulmonary rehabilitation intervention in patients with resectable hilar cholangiocarcinoma[J]. Journal of Clinical Medicine in Practice, 2022, 26(15): 75-79. DOI: 10.7619/jcmp.20220798
Citation: ZHU Jing, LI Xiangcheng, YIN Rong. Effect of pulmonary rehabilitation intervention in patients with resectable hilar cholangiocarcinoma[J]. Journal of Clinical Medicine in Practice, 2022, 26(15): 75-79. DOI: 10.7619/jcmp.20220798

Effect of pulmonary rehabilitation intervention in patients with resectable hilar cholangiocarcinoma

More Information
  • Received Date: March 13, 2022
  • Available Online: August 22, 2022
  • Objective 

    To investigate the effect of pulmonary rehabilitation intervention in patients with resectable hilar cholangiocarcinoma.

    Methods 

    A total of 100 patients with resectable hilar cholangiocarcinoma were randomly divided into intervention group and control group, with 50 cases in each group. The control group received routine nursing measures of enhanced recovery after surgery (ERAS), and the intervention group received pulmonary rehabilitation intervention on the basis of the control group. The intervention effect was compared between the two groups.

    Results 

    There were significant differences in postoperative pulmonary function, 6-minute walking distance, modified British medical research council (mMRC) score and the duration of 5 times of sit-up test between the intervention group and the control group(P < 0.05); the incidence of postoperative pulmonary complications, postoperative hospital stay and postoperative hospitalization costs in the intervention group were significantly lower or shorter than those in the control group (P < 0.05).

    Conclusion 

    Pulmonary rehabilitation intervention for patients with hilar cholangiocarcinoma surgery can effectively improve lung function, enhance exercise endurance, reduce the incidence of postoperative pulmonary complications, and promote rapid postoperative rehabilitation.

  • [1]
    李相成, 江王杰. 肝门部胆管癌诊治进展[J]. 腹部外科, 2019, 32(1): 7-12. doi: 10.3969/j.issn.1003-5591.2019.01.002
    [2]
    CHANDLER D, MOSIERI C, KALLURKAR A, et al. Perioperative strategies for the reduction of postoperative pulmonary complications[J]. Best PractResClinAnaesthesiol, 2020, 34(2): 153-166.
    [3]
    杨一枭, 冀洪峡, 赵娜. 围术期肺康复训练在肺癌患者中的研究进展[J]. 护理实践与研究, 2020, 17(19): 49-51. doi: 10.3969/j.issn.1672-9676.2020.19.017
    [4]
    汪庆, 赵妙香. 慢性阻塞性肺疾病康复期患者的心肺康复运动训练[J]. 实用临床医药杂志, 2020, 24(14): 79-82. doi: 10.7619/jcmp.202014021
    [5]
    JUNTERMANNS B, KAISERG M, REIS H, et al. Long-term Survival after resection for perihilar cholangiocarcinoma: impact of UICC staging and surgical procedure[J]. Turk J Gastroenterol, 2019, 30(5): 454-460. doi: 10.5152/tjg.2019.18275
    [6]
    李相成, 焦臣宇, 王科, 等. 肝门胆管癌根治性切除的结果和预后[J]. 外科理论与实践, 2016, 21(3): 206-211. https://www.cnki.com.cn/Article/CJFDTOTAL-WKLL201603010.htm
    [7]
    胡骁, 胡维昱, 孙传东, 等. 肝门部胆管癌根治性切除术后并发症的诊断和治疗[J]. 中国现代普通外科进展, 2015, 18(4): 328-330. https://www.cnki.com.cn/Article/CJFDTOTAL-PWJZ201504022.htm
    [8]
    GARUTTI I, ERRANDOC L, MAZZINARI G, et al. Spontaneous recovery of neuromuscular blockade is an independent risk factor for postoperative pulmonary complications after abdominal surgery: a secondary analysis[J]. EurJAnaesthesiol, 2020, 37(3): 203-211.
    [9]
    FERNANDES A, RODRIGUES J, LAGES P, et al. Root causes and outcomes of postoperative pulmonary complications after abdominal surgery: a retrospective observational cohort study[J]. Patient SafSurg, 2019, 13: 40.
    [10]
    郑树国, 项灿宏, 冯晓彬, 等. 肝门部胆管癌诊断和治疗指南(2013版)[J]. 中华外科杂志, 2013, 51(10): 865-871. doi: 10.3760/cma.j.issn.0529-5815.2013.10.001
    [11]
    郭剑, 周永斌, 翟泽民, 等. 肝门部胆管癌患者营养不良评估与术后并发症的相关研究[J]. 中华全科医学, 2016, 14(8): 1266-1268. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201608008.htm
    [12]
    COLLINSE G, BAULDOFF G, CARLIN B, et al. Clinical competency guidelines for pulmonary rehabilitation professionals: position statement of the American Association of Cardiovascular and Pulmonary Rehabilitation[J]. JCardiopulmRehabilPrev, 2014, 34(5): 291-302.
    [13]
    CHIUK L, HSIEHP C, WUC W, et al. Exercise training increases respiratory muscle strength and exercise capacity in patients with chronic obstructive pulmonary disease and respiratory muscle weakness[J]. Heart Lung, 2020, 49(5): 556-563. doi: 10.1016/j.hrtlng.2020.03.005
    [14]
    卢佳利. 立位呼吸操在心肺康复中的应用[J]. 世界最新医学信息文摘, 2019, 19(19): 19-20. https://www.cnki.com.cn/Article/CJFDTOTAL-WMIA201919018.htm
    [15]
    SAITO H, HATAKEYAMA K, KONNO H, et al. Impact of pulmonary rehabilitation on postoperative complications in patients with lung cancer and chronic obstructive pulmonary disease[J]. ThoracCancer, 2017, 8(5): 451-460.
    [16]
    吴倩倩, 方秀新, 吕小芹, 等. 基于加速康复外科理念的肺康复干预对腹部手术患者的影响[J]. 齐鲁护理杂志, 2020, 26(24): 5-8. https://www.cnki.com.cn/Article/CJFDTOTAL-QLHL202024002.htm
    [17]
    GAO K, YUP M, SUJ H, et al. Cardiopulmonary exercise testing screening and pre-operative pulmonary rehabilitation reduce postoperative complications and improve fast-track recovery after lung cancer surgery: a study for 342 cases[J]. ThoracCancer, 2015, 6(4): 443-449.
    [18]
    JONESS E, KONS S C, CANAVANJ L, et al. The five-repetition sit-to-stand test as a functional outcome measure in COPD[J]. Thorax, 2013, 68(11): 1015-1020.
    [19]
    邱玉珍, 陈惠玲, 陈丽. 心肺康复综合干预在老年上腹部手术患者临床护理中的应用[J]. 齐鲁护理杂志, 2020, 26(6): 80-82. https://www.cnki.com.cn/Article/CJFDTOTAL-QLHL202006027.htm
    [20]
    殷蓉, 徐莎莎, 李相成, 等. 肺康复训练方案在老年肝癌围术期患者中的应用[J]. 齐鲁护理杂志, 2019, 25(10): 37-40. https://www.cnki.com.cn/Article/CJFDTOTAL-QLHL201910016.htm
  • Related Articles

    [1]ZHU Rong, XIONG Zhaohui, CHEN Yunliang, LI Mengxin, WANG Haiquan. Effect of midazolam and dexmedetomidine in patients with septic shock during mechanical ventilation[J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 124-127. DOI: 10.7619/jcmp.20223579
    [2]ZHU Guanneng, WANG Yang, SONG Haimiao, FENG Erwen. Analysis of risk factors and pathogenic bacteria of ventilator-associated pneumonia in patients with severe trauma undergoing mechanical ventilation in intensive care unit[J]. Journal of Clinical Medicine in Practice, 2022, 26(10): 101-104. DOI: 10.7619/jcmp.20214843
    [3]LU Jun, LIN Qian, ZHANG Dan, HU Hong. Effect of cluster nursing on ventilation time and nursing quality in mechanical ventilation neonates[J]. Journal of Clinical Medicine in Practice, 2020, 24(7): 53-55. DOI: 10.7619/jcmp.202007016
    [4]YANG Xuefeng. Effect of milrinone combined with high frequency ventilation on arterial blood gas index and mechanical ventilation time in neonates with persistent pulmonary hypertension[J]. Journal of Clinical Medicine in Practice, 2018, (11): 33-35,40. DOI: 10.7619/jcmp.201811009
    [5]TAO Yu. Cluster nursing intervention in prevention of ventilator-associated pneumonia in patients with mechanical ventilation in RICU[J]. Journal of Clinical Medicine in Practice, 2018, (6): 26-29. DOI: 10.7619/jcmp.201806008
    [6]WANG Miao. Effect of mechanical vibration sputum elimination in reducing pulmonary complications in ICU patients with mechanical ventilation after operation[J]. Journal of Clinical Medicine in Practice, 2017, (10): 70-73. DOI: 10.7619/jcmp.201710022
    [7]PAN Jingya, WAN Wenxia, LI Xuemei. Nursing of RICU patients with mechanically ventilated in sequential ventilation critical period[J]. Journal of Clinical Medicine in Practice, 2016, (22): 27-29. DOI: 10.7619/jcmp.201622009
    [8]ZHANG Hong, SHEN Yuhui, CEHN Huaming. The curative effect analysis of nursing intervention on the continuous respiratory mechanical ventilation in treatment for neonatal respiratory failure[J]. Journal of Clinical Medicine in Practice, 2015, (18): 101-104. DOI: 10.7619/jcmp.201518032
    [9]CHEN Haiwei, LIANG Peng, SU Ning, WEN Jianhua, SU Meihua. The value and the influencing factors of modified sputum-sucking method in prevention and treatment of ventilator-associated pneumonia in patients with mechanical ventilation[J]. Journal of Clinical Medicine in Practice, 2015, (14): 27-29,42. DOI: 10.7619/jcmp.201514009
    [10]XIE Youhua, LU Hong, HUANG Chunye. Nursing experience of mechanical ventilation in patients with replacement of mitral valve[J]. Journal of Clinical Medicine in Practice, 2013, (10): 49-51. DOI: 10.7619/jcmp.201310019
  • Cited by

    Periodical cited type(31)

    1. 黄奇峰,郑鹏程,戴燕玲. 二甲双胍、阿卡波糖分别联用厄贝沙坦治疗糖尿病合并高血压的临床效果比较. 糖尿病新世界. 2024(04): 56-59+66 .
    2. 孙燕,张新菊,李雁. 卡格列净在基层糖尿病慢病管理中的疗效观察. 兵团医学. 2024(01): 54-56 .
    3. 黄延峰,钟荣惠. 甘精胰岛素搭配阿卡波糖和二甲双胍对糖尿病控制和氧化应激的影响研究. 现代医学与健康研究电子杂志. 2024(12): 51-54 .
    4. 程继华,孟俊娜,雷巧玲. 艾塞那肽治疗2型糖尿病的疗效及对胰岛素抵抗与糖脂代谢的影响研究. 中国医学工程. 2024(08): 88-92 .
    5. 贾志壮. 阿卡波糖联合二甲双胍治疗2型糖尿病的效果. 名医. 2024(09): 165-167 .
    6. 黄伟玲. 阿卡波糖联合二甲双胍治疗2型糖尿病对免疫功能及不良反应的影响. 临床合理用药. 2024(28): 103-105+115 .
    7. 任喆. 阿卡波糖联合二甲双胍在社区糖尿病患者糖代谢控制中的应用效果. 中国社区医师. 2024(32): 26-28 .
    8. 张秀丽,余玉花,张文帝. 二甲双胍联合阿卡波糖对2型糖尿病患者免疫功能、糖脂代谢的影响. 糖尿病新世界. 2024(18): 86-88+92 .
    9. 林钧,陈玮,刘进清. 视网膜激光光凝术与阿卡波糖联合治疗糖尿病性黄斑水肿的临床疗效. 糖尿病新世界. 2024(23): 187-190 .
    10. 岳斌,张巍,徐丽,郑华东,李明. 二甲双胍联合阿卡波糖治疗2型糖尿病的疗效及对免疫功能和NLRP3水平的影响. 海南医学. 2023(01): 14-18 .
    11. 耿瑶. 探究达格列净治疗2型糖尿病并心衰的临床疗效及其对炎性因子、血管内皮功能的影响. 黑龙江医学. 2023(05): 547-550 .
    12. 王鑫. 阿卡波糖联合二甲双胍治疗2型糖尿病的临床疗效观察. 现代诊断与治疗. 2023(01): 64-66+69 .
    13. 卢洁菲. 阿卡波糖联合二甲双胍对2型糖尿病患者免疫功能及炎性因子的影响. 甘肃医药. 2023(04): 318-319+325 .
    14. 景珊. 二甲双胍联合阿卡波糖用于糖尿病治疗的疗效及对HbA1c、FPG水平的影响分析. 糖尿病新世界. 2023(09): 76-79 .
    15. 孙嘉婧,于湘英,马子良. 阿卡波糖与二甲双胍在社区糖尿病治疗中的效果及对血糖的影响探析. 糖尿病新世界. 2023(10): 108-111+115 .
    16. 卢凯丽,宋瑞捧,姜惠惠,高红红. 阿卡波糖联合维格列汀治疗初治2型糖尿病的效果及对糖脂代谢的影响. 中国实用医刊. 2023(14): 109-112 .
    17. 方信英. 二甲双胍联合阿卡波糖在2型糖尿病患者中的应用效果分析. 糖尿病新世界. 2023(23): 81-84 .
    18. 仲伟慧. 阿卡波糖联合二甲双胍治疗2型糖尿病的疗效分析. 中国社区医师. 2022(06): 76-77+80 .
    19. 刘燕君,朱明敏,陈亚东. 二甲双胍与预混胰岛素联用对2型糖尿病患者血糖指标水平与不良反应的影响. 糖尿病新世界. 2022(05): 68-71 .
    20. 刘婷,王莹,杨召娣,陈继芳. 阿卡波糖联合二甲双胍治疗2型糖尿病对患者血糖水平、胰岛功能的影响. 现代医学与健康研究电子杂志. 2022(12): 142-144 .
    21. 王云枫,王彦贺. 阿卡波糖对2型糖尿病患者血脂及尿酸代谢的影响. 哈尔滨医药. 2022(03): 62-63 .
    22. 王学光. 二甲双胍联合阿卡波糖治疗2型糖尿病临床疗效分析. 糖尿病新世界. 2022(11): 102-105 .
    23. 陈聪,梁黎黎. 有氧-抗阻运动指导联合降糖药物对老年糖尿病患者的应用效果. 现代医学与健康研究电子杂志. 2022(21): 141-144 .
    24. 张建,范文文. DPP-4抑制剂联合阿卡波糖治疗初诊老年T2DM患者的疗效分析. 国际医药卫生导报. 2022(23): 3388-3391 .
    25. 黄文新. 瑞格列奈结合二甲双胍治疗2型糖尿病的疗效及对患者血糖水平的影响. 糖尿病新世界. 2021(07): 87-89 .
    26. 阳玲,黄冠军,方涛,柴振华,朱红艳. 二甲双胍联合阿格列汀或阿卡波糖治疗2型糖尿病的疗效对比. 药品评价. 2021(10): 621-623 .
    27. 徐露,章晓君. 阿卡波糖联合二甲双胍治疗糖尿病前期患者的效果分析. 现代医学与健康研究电子杂志. 2021(15): 51-53 .
    28. 房思思,屈桂茹. 拜糖平和二甲双胍治疗2型糖尿病的有效性及安全性研究. 中国药物滥用防治杂志. 2021(05): 682-684+703 .
    29. 周芸,刘路. 阿卡波糖联合二甲双胍对2型糖尿病患者血糖与肠促胰岛素水平的影响. 现代医学与健康研究电子杂志. 2021(18): 45-47 .
    30. 李黎,张瑞. 阿卡波糖联合二甲双胍用于治疗2型糖尿病临床效果分析. 世界复合医学. 2021(10): 195-198 .
    31. 宋先梅. 二甲双胍结合阿卡波糖治疗初发2型糖尿病伴高脂血症的临床效果分析. 中国现代药物应用. 2021(23): 139-141 .

    Other cited types(0)

Catalog

    Article views (177) PDF downloads (19) Cited by(31)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return